3SBio Inc - ESG Rating & Company Profile powered by AI
The ESG assessment for 3SBio Inc represents its reporting of the United Nations Sustainable Development Goals. The webpage of 3SBio Inc was assembled by All Street Sevva using leading Cognitive Robots. The analysis of 3SBio Inc employs data points from across the internet and also from public filings by 3SBio Inc.
3SBio Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.1; made up of an environmental score of 2.3, social score of 3.0 and governance score of 4.0.
3.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1733 | Timber Pharmaceuticals Inc | 3.2 | Medium |
| 1733 | Zhejiang Jiuzhou Pharmaceutical Co Ltd | 3.2 | Medium |
| 1760 | 3SBio Inc | 3.1 | Medium |
| 1760 | Anygen Co Ltd | 3.1 | Medium |
| 1760 | AptaBio Therapeutics Inc | 3.1 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does 3SBio Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes 3SBio Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes 3SBio Inc report the average age of the workforce?
Sign up for free to unlockDoes 3SBio Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes 3SBio Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes 3SBio Inc disclose cybersecurity risks?
Sign up for free to unlockDoes 3SBio Inc offer flexible work?
Sign up for free to unlockDoes 3SBio Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes 3SBio Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes 3SBio Inc conduct supply chain audits?
Sign up for free to unlockDoes 3SBio Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes 3SBio Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes 3SBio Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes 3SBio Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes 3SBio Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes 3SBio Inc disclose water use targets?
Sign up for free to unlockDoes 3SBio Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid 3SBio Inc have a product recall in the last two years?
Sign up for free to unlockDoes 3SBio Inc disclose incidents of discrimination?
Sign up for free to unlockDoes 3SBio Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas 3SBio Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes 3SBio Inc disclose parental leave metrics?
Sign up for free to unlockDoes 3SBio Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes 3SBio Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes 3SBio Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes 3SBio Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes 3SBio Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes 3SBio Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs 3SBio Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes 3SBio Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes 3SBio Inc disclose its waste policy?
Sign up for free to unlockDoes 3SBio Inc report according to TCFD requirements?
Sign up for free to unlockDoes 3SBio Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes 3SBio Inc disclose energy use targets?
Sign up for free to unlockDoes 3SBio Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes 3SBio Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for 3SBio Inc
These potential risks are based on the size, segment and geographies of the company.
3SBio Inc., an investment holding company, researches, develops, manufactures, markets, and sells biopharmaceutical products in the People's Republic of China. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; YISAIPU, a tumor necrosis factor for rheumatoid arthritis, ankylosing spondylitis, and psoriasis; EPIAO and SEPO recombinant human erythropoietins to treat anemia; and Cipterbin for HER2-positive metastatic breast cancer in combination with chemotherapy. It also offers Mandi to treat male alopecia and alopecia areata; Xenopax for preventing acute rejection after renal transplant; Byetta for the glycemic control in patients with type 2 diabetes; Qiming Keli to treat retinopathy caused by type 2 diabetic; Aiyishu for iron-deficiency anemia; and SPARIN, an injectable low-molecular-weight heparin calcium for the treatment of prophylaxis and deep vein thrombosis, as well as for the prevention of clotting during hemodialysis. In addition, it offers Intefen, a recombinant human interferon to treat lymphatic or hematopoietic malignancies and viral infections; and Inleusin, a human interleukin2 for the treatment of renal cell carcinoma, melanoma, and thoracic fluid build-up. Further, the company provides trading, project management and consultation, technology, and agricultural services. It has collaboration agreements with companies, such as AstraZeneca, Lilly, Toray Industries Inc, Samsung Bioepis, Refuge Biotechnologies, Verseau, TLC, Numab, GenSight, Sensorion, and Dana"Farber Cancer Institute. The company was founded in 1993 and is headquartered in Shenyang, the People's Republic of China.